Nishio K - Search Results

1

Effects of different combinations of gefitinib and irinotecan in lung cancer cell lines expressing wild or deletional EGFR.

Shimoyama T, Koizumi F, Fukumoto H, Kiura K, Tanimoto M, Saijo N, Nishio K. Shimoyama T, et al. Among authors: nishio k. Lung Cancer. 2006 Jul;53(1):13-21. doi: 10.1016/j.lungcan.2006.03.014. Epub 2006 May 19. Lung Cancer. 2006. PMID: 16713012

2

Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II).

Nishio K, Sugimoto Y, Kasahara K, Fujiwara Y, Nishiwaki S, Fujiki H, Ohata M, Saijo N. Nishio K, et al. Int J Cancer. 1992 Feb 1;50(3):438-42. doi: 10.1002/ijc.2910500319. Int J Cancer. 1992. PMID: 1310490

3

Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.

Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijo N. Kasahara K, et al. Among authors: nishio k. J Natl Cancer Inst. 1992 Jan 15;84(2):113-8. doi: 10.1093/jnci/84.2.113. J Natl Cancer Inst. 1992. PMID: 1310509

4

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Morikage T, Fujiwara Y, Saijo N. Sugimoto Y, et al. Among authors: nishio k. Br J Cancer. 1992 Jun;65(6):857-64. doi: 10.1038/bjc.1992.181. Br J Cancer. 1992. PMID: 1319727 Free PMC article.

5

Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.

Nishio K, Morikage T, Kubota N, Ohmori T, Takeda Y, Fujiwara Y, Miki K, Abe K, Saijo N. Nishio K, et al. Jpn J Cancer Res. 1992 Jul;83(7):754-60. doi: 10.1111/j.1349-7006.1992.tb01976.x. Jpn J Cancer Res. 1992. PMID: 1325432 Free PMC article.

6

In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Fujiwara Y, Saijo N. Sugimoto Y, et al. Among authors: nishio k. Cancer Chemother Pharmacol. 1992;30(6):417-22. doi: 10.1007/BF00685591. Cancer Chemother Pharmacol. 1992. PMID: 1327567

7

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line.

Kubota N, Kanzawa F, Nishio K, Takeda Y, Ohmori T, Fujiwara Y, Terashima Y, Saijo N. Kubota N, et al. Among authors: nishio k. Biochem Biophys Res Commun. 1992 Oct 30;188(2):571-7. doi: 10.1016/0006-291x(92)91094-7. Biochem Biophys Res Commun. 1992. PMID: 1332703

8

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

Niimi S, Nakagawa K, Sugimoto Y, Nishio K, Fujiwara Y, Yokoyama S, Terashima Y, Saijo N. Niimi S, et al. Among authors: nishio k. Cancer Res. 1992 Jan 15;52(2):328-33. Cancer Res. 1992. PMID: 1345810

9

Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II).

Nishio K, Sugimoto Y, Fujiwara Y, Ohmori T, Morikage T, Takeda Y, Ohata M, Saijo N. Nishio K, et al. J Clin Invest. 1992 May;89(5):1622-8. doi: 10.1172/JCI115758. J Clin Invest. 1992. PMID: 1569201 Free PMC article.

10

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.

Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Kasahara K, et al. Among authors: nishio k. Cancer Res. 1991 Jun 15;51(12):3237-42. Cancer Res. 1991. PMID: 1645616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters